BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 26338857)

  • 1. Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2.
    Ho PL; Law PY; Chan BW; Wong CW; To KK; Chiu SS; Cheng VC; Yam WC
    J Clin Microbiol; 2015 Nov; 53(11):3560-4. PubMed ID: 26338857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First Detection and Characterization of Macrolide-Resistant
    Noori Goodarzi N; Pourmand MR; Arfaatabar M; Azimi G; Masoorian E; Rahimi Foroushani A; Aminharati F; Heidarzadeh S; Baghani A
    Microb Drug Resist; 2020 Mar; 26(3):245-250. PubMed ID: 31545147
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase-shifting of the transmissibility of macrolide-sensitive and resistant Mycoplasma pneumoniae epidemics in Hong Kong, from 2015 to 2018.
    Zhao S; Musa SS; Qin J; He D
    Int J Infect Dis; 2019 Apr; 81():251-253. PubMed ID: 30822543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic diversity and macrolide resistance of Mycoplasma pneumoniae isolates from two consecutive epidemics in Slovenia.
    Kogoj R; Praprotnik M; Mrvič T; Korva M; Keše D
    Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):99-107. PubMed ID: 28948376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrolide-Resistant Mycoplasma pneumoniae, United States.
    Zheng X; Lee S; Selvarangan R; Qin X; Tang YW; Stiles J; Hong T; Todd K; Ratliff AE; Crabb DM; Xiao L; Atkinson TP; Waites KB
    Emerg Infect Dis; 2015 Aug; 21(8):1470-2. PubMed ID: 26196107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.
    Tanaka T; Oishi T; Miyata I; Wakabayashi S; Kono M; Ono S; Kato A; Fukuda Y; Saito A; Kondo E; Teranishi H; Tanaka Y; Wakabayashi T; Akaike H; Ogita S; Ohno N; Nakano T; Terada K; Ouchi K
    Emerg Infect Dis; 2017 Oct; 23(10):1703-1706. PubMed ID: 28930026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Clinical Features of Community-Acquired Pneumonia Caused by Macrolide-Resistant
    Choi JH; Seong GM; Ko Y; Kim YR; Kim C
    Microb Drug Resist; 2019 May; 25(4):577-581. PubMed ID: 30484744
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children.
    Lung DC; Yip EK; Lam DS; Que TL
    Pediatr Infect Dis J; 2013 Dec; 32(12):1396-9. PubMed ID: 23817339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization and analysis of Mycoplasma pneumoniae among patients of all ages with community-acquired pneumonia during an epidemic in China.
    Qu J; Chen S; Bao F; Gu L; Cao B
    Int J Infect Dis; 2019 Jun; 83():26-31. PubMed ID: 30926541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and Molecular Characteristics of Mycoplasma pneumoniae During an Outbreak of M. pneumoniae-associated Stevens-Johnson Syndrome.
    Watkins LKF; Olson D; Diaz MH; Lin X; Demirjian A; Benitez AJ; Winchell JM; Robinson CC; Bol KA; Glodé MP; Dominguez SR; Miller LA; Kutty PK
    Pediatr Infect Dis J; 2017 Jun; 36(6):564-571. PubMed ID: 28060039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014.
    Kogoj R; Mrvic T; Praprotnik M; Kese D
    Euro Surveill; 2015; 20(37):. PubMed ID: 26536357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple-locus variable-number tandem-repeat analysis (MLVA) of macrolide-susceptible and -resistant Mycoplasma pneumoniae in children in Taiwan.
    Lu CY; Yen TY; Chang LY; Liau YJ; Liu HH; Huang LM
    J Formos Med Assoc; 2020 Oct; 119(10):1539-1545. PubMed ID: 31924377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple-Locus Variable-Number Tandem-Repeat Analysis of Mycoplasma pneumoniae Isolates between 2004 and 2014 in Yamagata, Japan: Change in Molecular Characteristics during an 11-year Period.
    Suzuki Y; Seto J; Shimotai Y; Itagaki T; Katsushima Y; Katsushima F; Ikeda T; Mizuta K; Hongo S; Matsuzaki Y
    Jpn J Infect Dis; 2017 Nov; 70(6):642-646. PubMed ID: 29093323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju.
    Kim YJ; Shin KS; Lee KH; Kim YR; Choi JH
    J Korean Med Sci; 2017 Oct; 32(10):1642-1646. PubMed ID: 28875608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiclonal origin of macrolide-resistant Mycoplasma pneumoniae isolates as determined by multilocus variable-number tandem-repeat analysis.
    Liu Y; Ye X; Zhang H; Xu X; Wang M
    J Clin Microbiol; 2012 Aug; 50(8):2793-5. PubMed ID: 22649013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure.
    Cheong KN; Chiu SS; Chan BW; To KK; Chan EL; Ho PL
    J Microbiol Immunol Infect; 2016 Feb; 49(1):127-30. PubMed ID: 25556047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First Description of Macrolide-Resistant
    Loconsole D; De Robertis AL; Mallamaci R; Sallustio A; Morea A; Prato R; Quarto M; Martinelli D; Chironna M
    Biomed Res Int; 2019; 2019():7168949. PubMed ID: 31008110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program.
    Waites KB; Ratliff A; Crabb DM; Xiao L; Qin X; Selvarangan R; Tang YW; Zheng X; Dien Bard J; Hong T; Prichard M; Brooks E; Dallas S; Duffy L; Mixon E; Fowler KB; Atkinson TP
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31484701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China].
    Yin YD; Cao B; Wang H; Wang RT; Liu YM; Gao Y; Qu JX; Han GJ; Liu YN
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):954-8. PubMed ID: 24503430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients.
    Kawai Y; Miyashita N; Yamaguchi T; Saitoh A; Kondoh E; Fujimoto H; Teranishi H; Inoue M; Wakabayashi T; Akaike H; Ogita S; Kawasaki K; Terada K; Kishi F; Ouchi K
    Respirology; 2012 Feb; 17(2):354-62. PubMed ID: 22077195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.